AMRX Competitors & Alternatives
Compare Amneal Pharmaceuticals, Inc. Class A Common Stock with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
AMRX
Main Stock$18.32
Tradestie Score
57
Market Cap
$3.26B
P/E Ratio
51.4
Revenue Growth
0.0%
Analyst Upside
+2.3%
Top Competitors
45 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
|
$6.18
|
$7.83B | - | 45 | Compare |
|
ALKS
Alkermes Inc. plc
|
$48.99
|
$5.06B | 125.1 | 58 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$136.64
|
$3.98B | - | 56 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$99.64
|
$3.51B | 23.9 | 45 | Compare |
|
PBH
Prestige Consumer Healthcare Inc.
|
$50.22
|
$3.12B | 12.8 | 48 | Compare |
|
PRGO
PERRIGO COMPANY PLC
|
$10.11
|
$3.10B | - | 49 | Compare |
|
INDV
Indivior PLC Ordinary Shares
|
$40.01
|
$2.93B | 20.6 | 59 | Compare |
|
KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
|
$74.34
|
$2.86B | 82.3 | 58 | Compare |
|
HCM
HUTCHMED (China) Limited American Depositary Shares
|
$11.13
|
$2.74B | 4.3 | 44 | Compare |
|
SUPN
Supernus Pharmaceuticals, Inc.
|
$44.63
|
$2.69B | - | 44 | Compare |
More AMRX Analysis
Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
45 stocks in this industry